Prime Medicine, Inc.'s market cap is currently $958.69M. The company's EPS TTM is $-0.41; its P/E ratio is ―; Prime Medicine, Inc. is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
